Equities

BioSig Technologies Inc

BSGM:QBB

BioSig Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.25
  • Today's Change-0.003 / -1.30%
  • Shares traded32.12k
  • 1 Year change-94.60%
  • Beta0.6789
Data delayed at least 15 minutes, as of Oct 09 2024 17:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is designed to pinpoint even the complex signals to maximize procedural success and efficiency. The PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.

  • Revenue in USD (TTM)40.00k
  • Net income in USD-18.08m
  • Incorporated2011
  • Employees4.00
  • Location
    BioSig Technologies Inc55 Greens Farms RoadWESTPORT 06880United StatesUSA
  • Phone+1 (203) 409-5444
  • Fax+1 (302) 645-1280
  • Websitehttps://www.biosig.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Fuse Medical Inc18.40m3.63m3.33m31.001.25--0.90160.18070.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
Heart Test Laboratories Inc18.60k-7.29m3.71m15.00--0.6202--199.36-5.65-5.650.00116.550.00350.0092--1,240.00-135.14---193.38--67.31---39,193.76--4.02-20.720.0777--261.17---3.95------
Applied DNA Sciences Inc3.40m-7.52m3.80m53.00--0.3066--1.12-11.86-11.862.181.200.20926.835.6864,114.15-45.51-88.57-55.20-121.9125.0444.35-217.48-113.263.76--0.00---26.4327.92-18.73--33.80--
AccuStem Sciences Inc0.00-1.65m3.97m3.00---------0.1454-0.14540.00-0.25420.00----0.00-551.46--------------------------45.26------
Sonendo Inc37.46m-47.49m3.98m216.00--0.2226--0.1062-0.5017-0.44360.39520.24530.4981.956.91173,421.30-63.14---78.26--35.04---126.79--1.73-8.540.5194--5.30---6.78------
Telesis Bio Inc16.28m-50.12m3.98m137.00------0.2445-29.66-30.689.615.610.19473.153.40118,832.10-57.15---64.21--49.47---293.54--1.72-52.960.356--0.2697---1.14------
Optimus Healthcare Services Inc1.89m-7.16m4.03m12.00------2.13-0.1744-0.17440.0454-0.18891.26--3.67157,291.70-477.28------85.93---379.51-----5.42----22.88---3.51------
BioSig Technologies Inc40.00k-18.08m4.12m4.00------103.08-1.97-1.970.00410.00660.0112--1.0710,000.00-489.14-269.73-4,711.71-363.1165.00---43,760.00-24,485.73---3,115.670.00---93.71---6.52---9.58--
Predictive Oncology Inc1.75m-14.04m4.30m34.00--0.8997--2.46-3.36-3.360.41580.71710.11081.454.2851,425.29-88.98-91.80-121.17-126.2960.2364.64-802.93-1,419.991.37--0.0634--18.244.7545.67--5.44--
Caduceus Software Systems Corp0.00-117.60k4.35m0.00---------0.0004-0.00040.00-0.00040.00-------402.19-11,090.31---------------76.88---------20,519.89------
Sharps Technology Inc0.00-8.21m4.38m3.00--0.6069-----0.4944-0.49440.000.25240.00-------75.56---100.97----------0.6446--0.00-------112.12------
Kelyniam Global Inc517.70k-420.28k4.39m0.00--8.11--8.48-0.0253-0.02530.03120.01790.41357.044.38---33.57---41.79--18.86---81.18--1.26--0.6232---26.47---19.10------
Encision Inc6.56m-529.29k4.63m22.00--2.49--0.7056-0.045-0.0450.5560.15661.702.107.59298,337.30-13.69-3.03-19.50-4.1349.0051.25-8.06-1.891.01-8.890.1761---10.38-5.64-113.55---9.54--
Hawkeye Systems Inc0.00-578.72k4.79m44.00---------0.093-0.0930.00-0.30060.00-------117.01-314.04-----------195.39---1.49--------52.81------
Nu-Med Plus Inc0.00-112.13k4.87m2.00---------0.0014-0.00140.00-0.00220.00----0.00-471.23-447.69---------------21.34--------3.56------
Reflect Scientific Inc1.73m-53.09k5.05m7.00--2.5765.622.92-0.0006-0.00060.02030.0230.71970.846317.05247,638.60-2.2011.10-2.5913.2158.1962.48-3.0610.005.68--0.00---47.09-6.99-613.46------
Data as of Oct 09 2024. Currency figures normalised to BioSig Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

0.69%Per cent of shares held by top holders
HolderShares% Held
Jane Street Capital LLCas of 31 Mar 202443.82k0.31%
HRT Financial LLCas of 31 Mar 202426.33k0.19%
Truist Bank (Private Banking)as of 31 Mar 202411.23k0.08%
Tower Research Capital LLCas of 31 Mar 20247.05k0.05%
Webster Financial Advisorsas of 30 Jun 20244.00k0.03%
Morgan Stanley & Co. LLCas of 31 Mar 20242.66k0.02%
BlackRock Investment Management LLCas of 31 Mar 20241.03k0.01%
Steward Partners Investment Advisory LLCas of 30 Jun 2024900.000.01%
Redwood Wealth Management Group LLCas of 30 Jun 2024430.000.00%
Thrivent Trust Co.as of 30 Jun 2024300.000.00%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.